Buy or sell: Ganesh Dongre of Anand Rathi recommends three stocks to buy on Monday – 12 May | Stock Market News

Buy or sell: Ganesh Dongre of Anand Rathi recommends three stocks to buy on Monday – 12 May | Stock Market News

Source: Live Mint Buy or sell: This week, the Indian equity markets showcased notable resilience amid rising geopolitical tensions between India and Pakistan. While markets initially consolidated, they ended the week with only a modest decline. The Nifty index traded in a relatively tight range of 23800-24600 marks, before closing with a net weekly loss…

Read More
Buy or sell: Ganesh Dongre of Anand Rathi recommends four stocks to buy on Monday – 28 April | Stock Market News

Buy or sell: Ganesh Dongre of Anand Rathi recommends four stocks to buy on Monday – 28 April | Stock Market News

Source: Live Mint Buy or sell: Over the past three weeks, the Nifty Index has demonstrated a strong recovery, fueled by Foreign Institutional Investors (FIIs) purchasing stocks worth ₹30,000 crore in the cash market. This bullish momentum was underpinned by both global and domestic factors, notably U.S. President Donald Trump’s decision to pause the implementation…

Read More
Cipla, Sun Pharma, Ipca Labs, JB Pharma drive Indian pharma market growth in March’2025 | Stock Market News

Cipla, Sun Pharma, Ipca Labs, JB Pharma drive Indian pharma market growth in March’2025 | Stock Market News

Source: Live Mint Pharma Stocks; Indian Pharma market grew a a healthy 9.3% year on year during the month of March’2025 suggest reports. Cipla, Sun Pharmaceutical Industries, Ipca Laboratories Ltd, JB Chemicals & Pharmaceuticals Ltd (JB Pharma), Glenmark Pharmaceuticals Ltd were the key drivers of Indian pharma market growth during the month of March’2025. Pharma…

Read More
Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for 5 million; shares edge higher | Stock Market News

Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher | Stock Market News

Source: Live Mint Sun Pharmaceutical Industries Ltd. has announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology company, in a $355 million cash deal. The acquisition will bolster Sun Pharma’s onco-dermatology portfolio, adding Checkpoint’s recently FDA-approved cancer drug, UNLOXCYT (cosibelimab-ipdl), to its pipeline. The deal, expected to close in the second…

Read More
Stocks to watch: Tata Motors, Paytm, M&M, NLC India among shares to remain in focus today | Stock Market News

Stocks to watch: Tata Motors, Paytm, M&M, NLC India among shares to remain in focus today | Stock Market News

Source: Live Mint Here’s a quick look at stocks likely to be in focus in today’s trade. Tata Motors, Hyundai Motors, Maruti Maruti Suzuki recorded slight growth, whereas Hyundai and Tata Motors experienced a drop in sales in February, as market sluggishness persisted with subdued demand. Glenmark Pharma According to the US health regulator, Glenmark…

Read More
FPI sell-off, retail panic fuel sharp market correction; mid, small caps enter negative territory | Stock Market News

FPI sell-off, retail panic fuel sharp market correction; mid, small caps enter negative territory | Stock Market News

Source: Live Mint On a day global stock indices were battered by rising international trade tensions induced by US President Donald Trump, Indian markets followed their slump, with all gauges dipping sharply. Japan’s Nikkei and China’s CSI 300 fell 2.88% and 1.97%, respectively, amid weak openings for Germany’s Dax and French CAC. Almost on cue,…

Read More